Mark Lowdell
Founder bij INMUNE BIO, INC.
Vermogen: 18 M $ op 31-03-2024
Actieve functies van Mark Lowdell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
INMUNE BIO, INC. | Founder | 01-09-2015 | - |
Chief Tech/Sci/R&D Officer | 01-10-2015 | - | |
Director/Board Member | 01-09-2015 | 01-07-2018 | |
Corporate Officer/Principal | 01-09-2015 | - | |
University College London | Corporate Officer/Principal | 01-01-1994 | - |
Royal Free London NHS Foundation Trust
Royal Free London NHS Foundation Trust Hospital/Nursing ManagementHealth Services Royal Free London NHS Foundation Trust operates hospitals and clinics. The company was founded on July 1, 2014 and is headquartered in London, the United Kingdom. | Corporate Officer/Principal | 01-02-2009 | - |
Royal Free Hospital Medical School | Corporate Officer/Principal | - | - |
International Society For Cell & Gene Therapy | Corporate Officer/Principal | - | - |
Autolomous Ltd. | Director/Board Member | 01-02-2021 | - |
Founder | 01-02-2019 | - |
Loopbaan van Mark Lowdell
Eerdere bekende functies van Mark Lowdell
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Immune Ventures Ltd. | Founder | - | - |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Founder | 01-05-2016 | - |
ACHILLES THERAPEUTICS PLC | Founder | 01-11-2020 | - |
░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░ | - | - |
Opleiding van Mark Lowdell
St Bartholomew's Hospital Medical College | Doctorate Degree |
Blizard Institute | Doctorate Degree |
Statistieken
Internationaal
Verenigd Koninkrijk | 11 |
2 | |
Canada | 2 |
Operationeel
Founder | 6 |
Corporate Officer/Principal | 5 |
Director/Board Member | 2 |
Sectoraal
Consumer Services | 5 |
Health Technology | 4 |
Health Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ACHILLES THERAPEUTICS PLC | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Kuur Therapeutics Ltd.
Kuur Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Kuur Therapeutics provides clinical cellular therapeutics services. It develops, manufactures and markets personalized cellular immunotherapeutics for infectious disease and cancer. Cell Medica has developed proprietary production technology enabling GMP compliant manufacture of antigen-specific T cells. The company was founded by Gregg Sando in 2006 and is headquartered in London, the United Kingdom. | Health Technology |
Royal Free London NHS Foundation Trust
Royal Free London NHS Foundation Trust Hospital/Nursing ManagementHealth Services Royal Free London NHS Foundation Trust operates hospitals and clinics. The company was founded on July 1, 2014 and is headquartered in London, the United Kingdom. | Health Services |
Achilles Therapeutics UK Ltd.
Achilles Therapeutics UK Ltd. BiotechnologyHealth Technology Achilles Therapeutics Ltd. operates as a biopharmaceutical company. The firm develops personalized vaccines and adoptive T cell therapies to treat metastatic cancer. It uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. The company was founded by Karl Peggs, Mark Lowdell, Charles Swanton and Sergio Quezada in May 2016 and is headquartered in London, the United Kingdom. | Health Technology |
INmune Bio, Inc. | |
Immune Ventures Ltd. | |
International Society For Cell & Gene Therapy | |
Autolomous Ltd. |
- Beurs
- Insiders
- Mark Lowdell
- Ervaring